Wednesday - December 25, 2024

Methods of Treatment of Diseases in Which IL-13 Activity Is Detrimental Using Anti-Il-13 Antibodies

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- ABBVIE INC., North Chicago, Illinois has been assigned a patent (No. US 12129294 B2, initially filed Feb. 3, 2023) developed by four inventors Gregg Timony, Carlsbad, California; Sheila Gujrathi, Rancho Santa Fe, California; Robert Peach, San Diego, California; and Allan Olson, San Diego, California, for "Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Methods of Treatment of Diseases in Which IL-13 Activity Is Detrimental Using Anti-Il-13 Antibodies

Information Request Form

Copyright Targeted News Service 2024